Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
155.47
-1.26 (-0.80%)
Official Closing Price
Updated: 6:30 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Nasdaq, S&P 500 Futures Plunge After Trump's Comments And ASML's Weak Forecast Deepens Tech Sell-Off: AI Narrative May Be Priced In, Says Analyst
July 17, 2024
Sentiment will likely reverse course, with the index futures trading notably lower early Wednesday. The recent run-up ideally should render the mood cautious, and the caution may intensify as the first...
Via
Benzinga
Topics
Artificial Intelligence
Government
Stocks
Exposures
Artificial Intelligence
Political
US Equities
3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income
July 17, 2024
These high-yield dividend stocks will ensure steady quarterly income and help your money grow at little risk.
Via
InvestorPlace
Johnson & Johnson Earnings Top, But Dow Stock Falls On Lowered Guidance
July 17, 2024
The Dow giant reported before the open. Shares are in a long downtrend.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
Smart Money Is Betting Big In JNJ Options
July 15, 2024
Via
Benzinga
NYSE:JNJ: good value for what you're paying.
July 15, 2024
JOHNSON & JOHNSON (NYSE:JNJ) stands out as a stock that provides good value for the fundamentals it showcases.
Via
Chartmill
Looking At Johnson & Johnson's Recent Unusual Options Activity
July 08, 2024
Via
Benzinga
Johnson & Johnson reports Q2 2024 results
July 17, 2024
From
Johnson & Johnson
Via
Business Wire
ASML, United Airlines And 3 Other Stocks To Watch Heading Into Wednesday
July 17, 2024
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Dow Jones Closes At Record High As Traders Turn Bullish Amid Hopes Of Fed Cutting Rates In September
July 17, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index remaining in the "Greed" zone on Tuesday.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via
Benzinga
3 Safe Dividend Kings to Recession-Proof Your Portfolio
July 16, 2024
These safe dividend kings belong to an elite club of companies that have paid dividends for more than 50 years.
Via
InvestorPlace
Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings
July 16, 2024
Johnson & Johnson reports Q2 earnings, expected EPS of $2.7 and revenues of $22.3B. Stock is bullish, above key moving averages.
Via
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
July 16, 2024
JNJ to release 2Q financial results on July 17. Expected earnings $2.70/share, revenue $22.29B. Investors eye 3.32% dividend yield for gains.
Via
Benzinga
If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names
July 16, 2024
These dow stocks to buy are well-positioned to provide significant returns to investors due to their high growth potential.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Dow Closes At New High As Q2 Earnings Season Heats Up
July 16, 2024
It’s a great start to the trading week. After months of trailing its major-index brethren, the Dow Jones reaches today’s closing bell at a new record high: 40,211. Q2 earnings are coming in well so...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
July 15, 2024
From
NKGen Biotech
Via
GlobeNewswire
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
July 15, 2024
These companies stand out for their pedigrees, robust financials, and future growth prospects.
Via
The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist This Month
July 14, 2024
They don't have the most exciting businesses, but they have a lot to offer nonetheless.
Via
The Motley Fool
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
July 15, 2024
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the trend to reverse.
Via
Benzinga
3 High-Yield Dividend Stocks That Still Look Like Bargains
July 14, 2024
The prices of these reliable dividend payers haven't kept pace with the frothy stock market.
Via
The Motley Fool
MarketBeat Week in Review – 7/8 - 7/12
July 13, 2024
Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
3 Key Earnings Reports To Watch Next Week
July 13, 2024
With the 2024 Q2 earnings season kicking into a much higher gear next week, there are several reports investors should keep on their radars, including those from Netflix, Taiwan Semiconductor, and...
Via
Talk Markets
3 Essential Stocks for Building a Recession-Proof Portfolio
July 12, 2024
Secure your portfolio with these three recession-proof stocks, chosen for their consistent performance and long-term growth.
Via
InvestorPlace
Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
July 11, 2024
From
Johnson & Johnson
Via
Business Wire
3 Magnificent Dow Stocks That Are No-Brainer Buys for the Second Half of 2024
July 11, 2024
Among the Dow Jones Industrial Average's 30 time-tested components, there are three that stand out as phenomenal buys right now.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Undervalued Stocks Set to Outperform the Market in 2024
July 10, 2024
Discover the top three undervalued stocks poised for growth in the restaurant, pharmaceutical and footwear industries.
Via
InvestorPlace
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs
July 09, 2024
Johnson & Johnson is set to release its Q2 2024 earnings on July 17. Analysts estimate $22.29 billion in sales and an EPS of $2.71.
Via
Benzinga
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
July 09, 2024
Emergent BioSolutions and Janssen Pharmaceuticals settle disputes over SARS-CoV-2 vaccine manufacturing with a $50 million agreement, resolving all related claims and arbitration.
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.